Centessa Pharmaceuticals’ Poster Presentation of New Data from Additional 52-Weeks of Continuous Treatment from Part 5 of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia
Dec 10, 2023
American Society of Hematology (ASH) Annual Meeting 2023
Supporting Materials
ASH 2023 Poster for SerpinPC Part 5 939.3 KB